Adherence Behaviors and Related Factors Among Elderly Hypertensive Patients in China: Evidence from the China Health and Retirement Longitudinal Study

References

• Ma W. The national economy in 2022 tops the pressure to reach new heights. National Statistics Bureau; 2023. Available from: http://www.gov.cn/xinwen/2023-01/17/content_5737453.htm. Accessed January 17, 2023.
   Google Scholar
• Tang S, Xu Y, Li Z, Yang T, Qian D. Does economic support have an impact on the health status of elderly patients with chronic diseases in China? Based on CHARLS (2018) data research. Front Public Health. 2021;9:658830. doi:10.3389/fpubh.2021.658830
   PubMed Web of Science ®Google Scholar
• Jiang CH, Zhu F, Qin TT. Relationships between chronic diseases and depression among middle-aged and elderly people in China: a prospective study from CHARLS. Curr Med Sci. 2020;40(5):858–870. doi:10.1007/s11596-020-2270-5
   PubMed Web of Science ®Google Scholar
• Yang G, Kong L, Zhao W, et al. Emergence of chronic non-communicable diseases in China. Lancet. 2008;372(9650):1697–1705. doi:10.1016/S0140-6736(08)61366-5
   PubMed Web of Science ®Google Scholar
• Liu J, Rozelle S, Xu Q, Yu N, Zhou T. Social engagement and elderly health in China: evidence from the China Health and Retirement Longitudinal Survey (CHARLS). Int J Environ Res Public Health. 2019;16(2):278.
   PubMed Web of Science ®Google Scholar
• Tan S, Liu D, Zhang Y, Li S, Zhang K, Zuo H. Trends in blood pressure and hypertension among older adults and oldest-old individuals in China between 2008–2018. Hypertens Res. 2023;46(5):1145–1156. doi:10.1038/s41440-023-01183-4
   PubMed Web of Science ®Google Scholar
• Calas L, Subiros M, Ruello M, et al. Hypertension prevalence, awareness, treatment and control in 2019 in the adult population of Mayotte. Eur J Public Health. 2022;32(3):408–414. doi:10.1093/eurpub/ckac015
   PubMed Web of Science ®Google Scholar
• Yusuf S, Joseph P, Rangarajan S, et al. Modifiable risk factors, cardiovascular disease, and mortality in 155 722 individuals from 21 high-income, middle-income, and low-income countries (PURE): a prospective cohort study. Lancet. 2020;395(10226):795–808. doi:10.1016/S0140-6736(19)32008-2
   PubMed Web of Science ®Google Scholar
• Chen Y, Hu S, Wu L, Fang X, Xu W, Shen G. Clinical practice guidelines for hypertension in China: a systematic review of the methodological quality. BMJ Open. 2015;5(7):e008099. doi:10.1136/bmjopen-2015-008099
   PubMed Web of Science ®Google Scholar
• Liang X, Zhong H, Xiao L. The effect of community hypertension management on blood pressure control and its determinants in southwest China. Int Health. 2020;12(3):203–212. doi:10.1093/inthealth/ihaa002
   PubMed Web of Science ®Google Scholar
• Liao Y, Gilmour S, Shibuya K, Kokubo Y. Health insurance coverage and hypertension control in China: results from the China Health and Nutrition Survey. PLoS One. 2016;11(3):e0152091. doi:10.1371/journal.pone.0152091
   PubMed Web of Science ®Google Scholar
• Wang Z, Chen Z, Zhang L, et al. Status of hypertension in China: results from the China Hypertension Survey, 2012–2015. Circulation. 2018;137(22):2344–2356. doi:10.1161/CIRCULATIONAHA.117.032380
   PubMed Web of Science ®Google Scholar
• Feng XL, Pang M, Beard J. Health system strengthening and hypertension awareness, treatment and control: data from the China Health and Retirement Longitudinal Study. Bull World Health Organ. 2014;92(1):29–41. doi:10.2471/BLT.13.124495
   PubMed Web of Science ®Google Scholar
• Lu Y, Wang P, Zhou T, et al. Comparison of prevalence, awareness, treatment, and control of cardiovascular risk factors in China and the United States. J Am Heart Assoc. 2018;7(3). doi:10.1161/JAHA.117.007462
   Web of Science ®Google Scholar
• Mauer N, Geldsetzer P, Manne-Goehler J, et al. Longitudinal evidence on treatment discontinuation, adherence, and loss of hypertension control in four middle-income countries. Sci Transl Med. 2022;14(652):eabi9522. doi:10.1126/scitranslmed.abi9522
   PubMed Web of Science ®Google Scholar
• Feng Y, Guan S, Xu Y, et al. Effects of the two-dimensional structure of trust on patient adherence to medication and non-pharmaceutical treatment: a cross-sectional study of rural patients with essential hypertension in China. Front Public Health. 2022;10:818426. doi:10.3389/fpubh.2022.818426
   PubMed Web of Science ®Google Scholar
• Sheilini M, Hande HM, Devi ES, et al. Determinants of adherence to antihypertensives among elderly: a multifactorial concern. Patient Prefer Adherence. 2022;16:3185–3193. doi:10.2147/PPA.S389437
   PubMed Web of Science ®Google Scholar
• Kim JS, Kim CG. Gender differences in hypertension treatment and control in young adults. J Nurs Res. 2020;28(3):e88. doi:10.1097/JNR.0000000000000359
   PubMedGoogle Scholar
• Lu J, Lu Y, Wang X, et al. Prevalence, awareness, treatment, and control of hypertension in China: data from 1.7 million adults in a population-based screening study (China PEACE Million Persons Project). Lancet. 2017;390(10112):2549–2558. doi:10.1016/S0140-6736(17)32478-9
   PubMed Web of Science ®Google Scholar
• Ferdinand KC, Yadav K, Nasser SA, et al. Disparities in hypertension and cardiovascular disease in blacks: the critical role of medication adherence. J Clin Hypertens. 2017;19(10):1015–1024. doi:10.1111/jch.13089
   Web of Science ®Google Scholar
• Zhou B, Carrillo-Larco RM, Danaei G, et al. Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. doi:10.1016/S0140-6736(21)01330-1
   PubMed Web of Science ®Google Scholar
• Chisholm-Burns MA, Spivey CA. The ‘cost’ of medication nonadherence: consequences we cannot afford to accept. J Am Pharm Assoc. 2012;52(6):823–826. doi:10.1331/JAPhA.2012.11088
   Google Scholar
• Fletcher BR, Hartmann-Boyce J, Hinton L, McManus RJ. The effect of self-monitoring of blood pressure on medication adherence and lifestyle factors: a systematic review and meta-analysis. Am J Hypertens. 2015;28(10):1209–1221. doi:10.1093/ajh/hpv008
   PubMed Web of Science ®Google Scholar
• Stergiou GS, Kario K, Kollias A, et al. Home blood pressure monitoring in the 21st century. J Clin Hypertens. 2018;20(7):1116–1121. doi:10.1111/jch.13284
   Web of Science ®Google Scholar
• Zahid H, Amin A, Amin E, et al. Prevalence and predictors of use of home sphygmomanometers among hypertensive patients. Cureus. 2017;9(4):e1155. doi:10.7759/cureus.1155
   PubMedGoogle Scholar
• Peng MD, Gong YC, Ding JL. 南通市社区高血压患者家庭血压计持有及血压自测情况研究[A study of home blood pressure monitor possession and blood pressure self-testing in community hypertensive patients in Nantong city]. Chongqing Med. 2017;46(24):3387–3389. Chinese.
   Google Scholar
• Wang YH. 高血压患者自我监测对血压控制率的影响[Effect of self-monitoring on blood pressure control rate in hypertensive patients]. Chin J Pract Neurol Disord. 2010;13(14):74–75. Chinese.
   Google Scholar
• Zuo HJ, Ma JX, Wang JW, Chen XR. Assessing the routine-practice gap for home blood pressure monitoring among Chinese adults with hypertension. BMC Public Health. 2020;20(1):1770. doi:10.1186/s12889-020-09901-0
   PubMed Web of Science ®Google Scholar
• Oori MJ, Mohammadi F, Norouzi K, Fallahi-Khoshknab M, Ebadi A. Conceptual model of medication adherence in older adults with high blood pressure-an integrative review of the literature. Curr Hypertens Rev. 2019;15(2):85–92. doi:10.2174/1573402114666181022152313
   PubMed Web of Science ®Google Scholar
• Weiner BJ, Lewis MA, Clauser SB, Stitzenberg KB. In search of synergy: strategies for combining interventions at multiple levels. J Natl Cancer Inst Monogr. 2012;2012(44):34–41. doi:10.1093/jncimonographs/lgs001
   PubMedGoogle Scholar
• Zhao Y, Hu Y, Smith JP, Strauss J, Yang G. Cohort profile: the China Health and Retirement Longitudinal Study (CHARLS). Int J Epidemiol. 2014;43(1):61–68. doi:10.1093/ije/dys203
   PubMed Web of Science ®Google Scholar
• Wu Y, Wang H, Tong Y, et al. Sarcopenia index based on serum creatinine and cystatin C is associated with mortality in middle-aged and older adults in Chinese: a retrospective cohort study from the China Health and Retirement Longitudinal Study. Front Public Health. 2023;11:1122922. doi:10.3389/fpubh.2023.1122922
   PubMed Web of Science ®Google Scholar
• Hu K, Keenan K, Hale JM, Liu Y, Kulu H, Joshi SK. A longitudinal analysis of PM2.5 exposure and multimorbidity clusters and accumulation among adults aged 45–85 in China. PLOS Glob Public Health. 2022;2(6):e0000520. doi:10.1371/journal.pgph.0000520
   PubMedGoogle Scholar
• Pan Y, Pikhart H, Bobak M, Pikhartova J. Labour-market characteristics and self-rated health: evidence from the China Health and Retirement Longitudinal Study. Int J Environ Res Public Health. 2023;20(6):4748. doi:10.3390/ijerph20064748
   PubMedGoogle Scholar
• Statistical Information Center of the National Health and Wellness Commission. Report of the Sixth National Health Services Statistical Survey (2018). 1st ed. Beijing: People’s Medical Publishing House; 2021.
   Google Scholar
• Wei J, Mi Y, Li Y, Xin B, Wang Y. Factors associated with awareness, treatment and control of hypertension among 3579 hypertensive adults in China: data from the China Health and Nutrition Survey. BMC Public Health. 2021;21(1):423. doi:10.1186/s12889-021-10417-4
   PubMed Web of Science ®Google Scholar
• Choi HY, Oh IJ, Lee JA, et al. Factors affecting adherence to antihypertensive medication. Korean J Fam Med. 2018;39(6):325–332. doi:10.4082/kjfm.17.0041
   PubMed Web of Science ®Google Scholar
• Wang Y, Wang Y, Gu H, et al. Use of home blood pressure monitoring among hypertensive adults in primary care: Minhang community survey. Blood Press Monit. 2014;19(3):140–144. doi:10.1097/MBP.0000000000000035
   PubMed Web of Science ®Google Scholar
• Liu X, Gu W, Li Z, Lei H, Li G, Huang W. Hypertension prevalence, awareness, treatment, control, and associated factors in Southwest China: an update. J Hypertens. 2017;35(3):637–644. doi:10.1097/HJH.0000000000001203
   PubMed Web of Science ®Google Scholar
• Backholer K, Peters SAE, Bots SH, Peeters A, Huxley RR, Woodward M. Sex differences in the relationship between socioeconomic status and cardiovascular disease: a systematic review and meta-analysis. J Epidemiol Community Health. 2017;71(6):550–557. doi:10.1136/jech-2016-207890
   PubMed Web of Science ®Google Scholar
• Mamaghani EA, Hasanpoor E, Maghsoodi E, Soleimani F. Barriers to medication adherence among hypertensive patients in deprived rural areas. Ethiop J Health Sci. 2020;30(1):85–94. doi:10.4314/ejhs.v30i1.11
   PubMed Web of Science ®Google Scholar
• Brown MT, Bussell J, Dutta S, Davis K, Strong S, Mathew S. Medication adherence: truth and consequences. Am J Med Sci. 2016;351(4):387–399. doi:10.1016/j.amjms.2016.01.010
   PubMed Web of Science ®Google Scholar
• Uchmanowicz B, Jankowska EA, Uchmanowicz I, Morisky DE. Self-reported medication adherence measured with morisky medication adherence scales and its determinants in hypertensive patients aged ≥60 years: a systematic review and meta-analysis. Front Pharmacol. 2019;10:168. doi:10.3389/fphar.2019.00168
   PubMed Web of Science ®Google Scholar
• Chia YC, Devaraj NK, Ching SM, et al. Relationship of an adherence score with blood pressure control status among patients with hypertension and their determinants: findings from a nationwide blood pressure screening program. J Clin Hypertens. 2021;23(3):638–645. doi:10.1111/jch.14212
   Web of Science ®Google Scholar
• Chang SM, Lu IC, Chen YC, Hsuan CF, Lin YJ, Chuang HY. Behavioral factors associated with medication nonadherence in patients with hypertension. Int J Environ Res Public Health. 2021;18(18):9614. doi:10.3390/ijerph18189614
   PubMed Web of Science ®Google Scholar
• Trefond J, Hermet L, Lambert C, et al. Home blood pressure monitoring and adherence in patients with hypertension on primary prevention treatment: a survey of 1026 patients in general medicine in the Auvergne region. BMC Prim Care. 2022;23(1):131. doi:10.1186/s12875-022-01725-8
   PubMedGoogle Scholar
• Amico KR, Mugavero M, Krousel-Wood MA, Bosworth HB, Merlin JS. Advantages to using social-behavioral models of medication adherence in research and practice. J Gen Intern Med. 2018;33(2):207–215. doi:10.1007/s11606-017-4197-5
   PubMed Web of Science ®Google Scholar
• Shi D, Li J, Wang Y, et al. Association between health literacy and hypertension management in a Chinese community: a retrospective cohort study. Intern Emerg Med. 2017;12(6):765–776. doi:10.1007/s11739-017-1651-7
   PubMed Web of Science ®Google Scholar
• Graffigna G, Barello S, Bonanomi A, Cipresso P. The role of Patient Health Engagement Model (PHE-model) in affecting patient activation and medication adherence: a structural equation model. PLoS One. 2017;12(6):e0179865. doi:10.1371/journal.pone.0179865
   PubMed Web of Science ®Google Scholar
• Xiong S, Jiang W, Meng R, et al. Factors associated with the uptake of national essential public health service package for hypertension and type-2 diabetes management in China’s primary health care system: a mixed-methods study. Lancet Reg Health West Pac. 2023;31:100664. doi:10.1016/j.lanwpc.2022.100664
   PubMedGoogle Scholar
• Sun Y, Li Z, Guo X, et al. Rationale and design of a cluster randomized trial of a village doctor-led intervention on hypertension control in China. Am J Hypertens. 2021;34(8):831–839. doi:10.1093/ajh/hpab038
   PubMed Web of Science ®Google Scholar
• Tan JP, Cheng KKF, Siah RC. A systematic review and meta-analysis on the effectiveness of education on medication adherence for patients with hypertension, hyperlipidaemia and diabetes. J Adv Nurs. 2019;75(11):2478–2494. doi:10.1111/jan.14025
   PubMed Web of Science ®Google Scholar
• Bancej CM, Campbell N, McKay DW, Nichol M, Walker RL, Kaczorowski J. Home blood pressure monitoring among Canadian adults with hypertension: results from the 2009 Survey on Living with Chronic Diseases in Canada. Can J Cardiol. 2010;26(5):e152–e157. doi:10.1016/S0828-282X(10)70382-2
   PubMedGoogle Scholar
• Sudharsanan N, Ali MK, McConnell M. Hypertension knowledge and treatment initiation, adherence, and discontinuation among adults in Chennai, India: a cross-sectional study. BMJ Open. 2021;11(1):e040252. doi:10.1136/bmjopen-2020-040252
   PubMed Web of Science ®Google Scholar
• Raja W, Ayub T, Jeelani A, Khan SMS. Adherence to antihypertensive therapy and its determinants among patients attending primary care hospitals of Kashmir, India. J Family Med Prim Care. 2021;10(11):4153–4159. doi:10.4103/jfmpc.jfmpc_668_21
   PubMedGoogle Scholar
• Teshome DF, Demssie AF, Zeleke BM, Shimosawa T. Determinants of blood pressure control amongst hypertensive patients in Northwest Ethiopia. PLoS One. 2018;13(5):e0196535. doi:10.1371/journal.pone.0196535
   PubMed Web of Science ®Google Scholar